Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BCG-vaccinated cattle less infectious to other cattle, study finds
The UK government is currently conducting its own research into a deployable vaccine for cattle.
Study in Ethiopia suggests elimination of bovine TB in country is possible.

TB-infected cattle that have previously been given the Bacillus Calmette-Guérin (BCG) vaccine are less infectious to other cattle, a new study has found.
 
The research, led by the University of Cambridge and Penn State University, found that the BCG vaccine reduced TB transmission between cattle by 74 per cent per cent.

It is the first time this indirect benefit of the vaccine has been measured by scientists.

Conducted in Ethiopia, the study made use of livestock census and movement data to develop a transmission model.

Ethopia has the largest cattle population in Africa, but currently lacks a control programme for bovine TB. Intensive testing and slaughtering infected animals, as carried out in countries such as the UK, is considered to be unfeasible to implement in Ethiopia and other similar countries due to social and economic reasons.

Professor Conlan, associate professor of epidemiology at the University of Cambridge's Department of Veterinary Medicine and one of the authors of the study, said: "Results of the model suggest that vaccinating calves within the dairy sector of Ethiopia could reduce the reproduction number of the bacterium -- the R0 -- to below 1, arresting the projected increase in the burden of disease and putting herds on a pathway towards elimination of TB.”

The UK government is currently conducting its own research into creating a deployable vaccine and new DIVA skin test for bovine TB. Currently, the UK does not use the BCG vaccine because it can lead to vaccinated cattle giving false positive test results.

James Wood, Alborada professor of equine and farm animal science at the University of Cambridge's Department of Veterinary Medicine, said: "For over twenty years the UK government has pinned hopes on cattle vaccination for bovine tuberculosis as a solution to reduce the disease and the consequent costs of the controls.

“These results provide important support for the epidemiological benefit that cattle vaccination could have to reduce rates of transmission to and within herds."

The study has been published in the journal Science.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.